BPH - Benign Prostatic Enlargement
Emerging therapies: What's new is old and what's old is new - Abstract
November 14, 2012
Preperitoneal single-port transvesical enucleation of the prostate (STEP) for large-volume BPH: One-year follow-up of Qmax, IPSS, and QoL - Abstract
November 14, 2012
Incidence and progression of lower urinary tract symptoms in a large prospective cohort of United States men - Abstract
November 12, 2012
Associations between improvements in lower urinary tract symptoms and sleep disturbance over time in the CAMUS trial - Abstract
November 5, 2012
Impact of preoperative therapy with 5-α-reductase inhibitors in the treatment of benign prostatic hyperplasia - Abstract
November 2, 2012
Real-world use of Permixon® in benign prostatic hyperplasia - determining appropriate monotherapy and combination treatment - Abstract
November 1, 2012
Thulium laser (Revolix) vapoenucleation of the prostate is a safe procedure in patients with an increased risk of hemorrhage - Abstract
October 30, 2012
Interventional therapies for lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) - Abstract
October 29, 2012
Acute urinary retention increases the risk of complications after transurethral resection of the prostate: A population-based study - Abstract
October 29, 2012
LUTS and sleep disorders: Emerging risk factor - Abstract
October 26, 2012